Peptide record

TPDB41422

CTCE-9908 (Synthetic) dimer Anticancer Tumor-homing Peptides standard
8 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB41422
CTCE-9908 (Synthetic) dimer
Anticancer Tumor-homing Peptides
Cancer-related peptides
Peptipedia StackTHP StackTHPred TumorHoPe2.0
standard
No
A 8-aa standard natural multi-activity (Anticancer and Tumor-homing Peptides) peptide sequence curated from Peptipedia, StackTHP, StackTHPred, and other sources, with an available 3D structural model.
N-terminal: Attachment of lysine for dimer formation
Sequence
KGVSLSYR
Physicochemical Analysis
C40H68N12O12
ANDCEQHIMFPTW
S
909.05
10.42
2
0
3
+2
0.64
-0.462
85.00
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
1490
163.91
3
Residue Composition
number
0
A
1
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
0
I
1
L
1
K
0
M
0
F
0
P
2
S
0
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 0 L: 1 K: 1 M: 0 F: 0 P: 0 S: 2 T: 0 W: 0 Y: 1 V: 1
Chemical Descriptors
8
C40H68N12O12
909.05
10.42
+2
0.64
-0.462
Attachment of lysine for dimer formation
Evidence Records 1 records
Evidence 1 Activity

Activity

Tumor-homing Peptides

Target

Endothelial cell
Homing
Breast cancer
SDF-1/CXCR4 ligand/receptor pair

Source & Reference

TumorHoPe2.0
TumorHoPe2
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model.
2011
Hassan S et al. Int J Cancer. 2011 Jul 1 129(1):225-32.
US 2011/011 8193A1

Other

Source Activity Label Source Definition
Tumor-homing Peptides
TumorHoPe2.0 experimentally validated tumor-homing peptide annotation.
Tansgenic mouse model for breast cancer, mouse mammary tumor virus (MMTV)-driven Polyoma Middle T Antigen (PyMT) model
Synthetic
Docetaxel or DC101 (an anti-VEGFR2 monoclonal antibody)
KGVSLSYR-KNH2-KGVSLSYR
Additional Detail Fields 2 fields
Docetaxel or DC101 (an anti-VEGFR2 monoclonal antibody)
Tansgenic mouse model for breast cancer, mouse mammary tumor virus (MMTV)-driven Polyoma Middle T Antigen (PyMT) model